Results 21 to 30 of about 2,908,473 (270)

Spectral signature of a free pulsar wind in the gamma-ray binaries LS 5039 and LSI +61$\degr$303 [PDF]

open access: yes, 2008
LS 5039 and LSI +61$\degr$303 are two binaries that have been detected in the TeV energy domain. These binaries are composed of a massive star and a compact object, possibly a young pulsar.
Aharonian   +35 more
core   +4 more sources

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann   +17 more
wiley   +1 more source

Long Term X-ray Monitoring Of The TeV Binary LS I +61 303 with RXTE

open access: yes, 2008
We report on the results of a long term X-ray monitoring campaign of the galactic binary LS I +61 303 performed by the Rossi X-ray Timing Explorer. This dataset consists of 1 ks pointings taken every other day between 2007 August 28 until 2008 February 2.
A. Falcone   +26 more
core   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

open access: yesArthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY

open access: yesArthritis Care &Research, Accepted Article.
Objective Mycophenolate Mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon due to the lower fibrotic burden and the predominance of the vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

On a selection principle for multivalued semiclassical flows [PDF]

open access: yes, 2014
We study the semiclassical behaviour of solutions of a Schr ̈odinger equation with a scalar po- tential displaying a conical singularity. When a pure state interacts strongly with the singularity of the flow, there are several possible classical ...
Athanassoulis, Agissilaos   +2 more
core  

Review on the multiwavelength emission of the gamma-ray binary LS I +61 303

open access: yes, 2018
Gamma-ray binaries are systems composed of a massive star and a compact object that produce emission from radio to very high energy gamma-rays. LS I +61 303 is one of the only six gamma-ray binaries discovered so far.
Marcote, B.
core   +1 more source

Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy